Search results for "Urinary tract infections"


 
Results 21 - 30 of about 69 for "Urinary tract infections".
Sort by: Relevance | Newest | Oldest

More options available for psoriatic arthritis

Internists are the first doctors patients see for joint pain, which means they can make a big difference in preventing the progression of joint diseases such as psoriatic arthritis.
https://immattersacp.org/archives/2019/04/more-options-available-for-psoriatic-arthritis.htm
1 Apr 2019

MKSAP Quiz: 6-month history of fatigue, arthralgia, myalgia

A 27-year-old woman is evaluated for a 6-month history of fatigue, arthralgia, and myalgia. She has a history of urinary tract infections. Medications are an oral contraceptive pill and as-needed naproxen for pain. Following a physical exam, lab studies, and urine microscopy, what is the most likely diagnosis?
https://immattersacp.org/archives/2019/04/mksap-quiz-6-month-history-of-fatigue-arthralgia-myalgia.htm
1 Apr 2019

New cardiovascular indication approved for diabetes drug

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/04/new-cardiovascular-indication-approved-for-diabetes-drug.htm
1 Apr 2022

Managing patients with diabetes and heart failure

Good control of diabetes in the presence of heart failure includes appropriate HbA1c targets, metformin and comprehensive lifestyle change as first-line therapy, and a team approach.
https://immattersacp.org/archives/2019/11/managing-patients-with-diabetes-and-heart-failure.htm
1 Nov 2019

‘UTI’ an overused diagnosis in the era of the microbiome

An evolving understanding of urinary tract infections has led one expert to describe them as an “ambiguous, expansive, overused diagnosis” that can lead to the myriad harms of antibiotic overtreatment.
https://immattersacp.org/archives/2018/02/uti-an-overused-diagnosis-in-the-era-of-the-microbiome.htm
1 Feb 2018

Label change for pioglitazone-containing medications

This column reviews a label change for medicine that contain pioglitazone and a new indication for empagliflozin.
https://immattersacp.org/archives/2017/02/fda.htm
1 Feb 2017

SGLT-2 inhibitors not associated with increased risk for severe UTIs

An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.
https://immattersacp.org/weekly/archives/2019/07/30/1.htm
30 Jul 2019

Internists interacting with retail clinics

Primary care physicians are seeing more patients after they've already been to a retail health clinic. Experts say that a more patient-centered model needs to evolve to combat the ease of seeking care outside the doctor's office.
https://immattersacp.org/archives/2016/02/retail-clinics.htm
1 Feb 2016

Latest diabetes drugs have a learning curve

The onus is on internists to understand the newer classes of incretins such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. They hold promise for better treatments, but they are new and not as well understood as older treatments.
https://immattersacp.org/archives/2015/10/diabetes.htm
1 Oct 2015

CDC reports new data on hospital-acquired infections

The CDC released 2 different reports on hospital-acquired infection (HAI) rates in the U.S. last week.
https://immattersacp.org/weekly/archives/2014/04/01/5.htm
1 Apr 2014

Result Page: Prev   1   2   3   4   5   6   7   Next